The European Patent Office rules in the latest installment of the prosecution of the WARF patents.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Wisconsin Alumni Research Foundation, G 0002/06, 25 November, 2008.
EP 0 770 125.
European Directive 98/44/EC on the Legal Protection of Biotechnology Inventions.
Article 53(a) of the EPC.
Recital 42 of the European Directive 98/44/EC on the Legal Protection of Biotechnology Inventions.
UKIPO Practice Notice: Inventions Involving Human Embryonic Stem Cells, 3 February 2009.
Monsanto v. Cefetra, District Court of The Hague, 249983/HA ZA 05/2885, 19 March 2008.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fitt, R. New guidance on the patentability of embryonic stem cell patents in Europe. Nat Biotechnol 27, 338–339 (2009). https://doi.org/10.1038/nbt0409-338
Issue Date:
DOI: https://doi.org/10.1038/nbt0409-338